AG
GILD icon

Advocate Group’s Gilead Sciences GILD Stock Holding History

Advocate Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-77,431
Closed -$8.68M – 122
2025
Q1 		$8.68M Sell
77,431
-2,014
-3% -$208K 1.58% 24
2024
Q4 		$7.34M Buy
79,445
+751
+1% +$67.6K 1.38% 33
2024
Q3 		$6.6M Buy
78,694
+1,044
+1% +$79.7K 1.2% 38
2024
Q2 		$5.33M Buy
77,650
+3,580
+5% +$239K 1.07% 42
2024
Q1 		$5.43M Buy
74,070
+2,146
+3% +$165K 1.08% 43
2023
Q4 		$5.83M Buy
71,924
+88
+0.1% +$6.85K 1.25% 32
2023
Q3 		$5.38M Sell
71,836
-1,071
-1% -$82.4K 1.25% 33
2023
Q2 		$5.62M Sell
72,907
-152
-0.2% -$12.1K 1.24% 32
2023
Q1 		$6.06M Buy
73,059
+1,406
+2% +$116K 1.32% 32
2022
Q4 		$6.15M Buy
71,653
+5,494
+8% +$435K 1.32% 31
2022
Q3 		$4.08M Buy
66,159
+12,767
+24% +$805K 1.01% 42
2022
Q2 		$3.3M Buy
+53,392
New +$3.31M 0.77% 49

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advocate Group's GILD Position: Q2 2025 in Review

Advocate Group sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 77,431 shares — an estimated $8.68M sold.

Advocate Group first reported a position in GILD in Q2 2022 and held it in 12 quarters. The position peaked at $8.68M in Q1 2025. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Advocate Group reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Advocate Group sold 77,431 Gilead Sciences shares in Q2 2025, an estimated $8.68M.
  • Advocate Group first reported a position in Gilead Sciences in Q2 2022 and held it in 12 quarters.
  • Advocate Group's Gilead Sciences position peaked at $8.68M in Q1 2025.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Advocate Group's 13F filing for Q2 2025, filed 25 Jul 2025.